Analyst Price Targets for CRH plc (NYSE: CRH): What’s the Investment Outlook for the Building Materials Giant?

Font: Financial Modeling Prep  • Oct 09, 2026

• RBC Capital lowered its price target for CRH plc (NYSE: CRH) to $135.00 from $165.00 while maintaining an Outperform rating.
• Based on a reported share price of $82.00, RBC’s revised target implies approximately 64.63% potential upside.
• Although several analysts have recently lowered their targets, their ratings generally remain positive, with recently cited targets ranging from $105.00 to $140.00.

CRH plc (NYSE: CRH) is a leading building materials company that supplies products used in construction and infrastructure projects. RBC Capital recently lowered its price target for CRH to $135.00 from $165.00 while maintaining an Outperform rating. With CRH trading at approximately $82.00 when the update was published, the revised target implies about 64.63% potential upside.

A price target represents an analyst’s estimate of where a stock may trade over a specified period and does not guarantee future performance. RBC’s adjustment reduces its target by $30.00, or approximately 18.18%. Despite the reduction, the new target remains well above CRH’s reported share price.

The adjustment comes after CRH shares recently traded near their 52-week low. On October 5, the stock fell as low as $80.29 and was last quoted at approximately $80.21, down about 2.10% from its previous close of $81.94. The decline followed Truist Financial’s decision to lower its price target from $130.00 to $105.00 while maintaining a Buy rating.

Other analysts have also revised their expectations. Wells Fargo lowered its target from $107.00 to $106.00 while maintaining an Overweight rating. Berenberg reduced its target from $146.00 to $140.00 and maintained a Buy rating. Stephens lowered its target from $125.00 to $105.00 while retaining an Overweight rating.

Jefferies’ latest reported action reduced its CRH price target from $159.50 to $126.50 while maintaining a Buy rating. The firm had previously raised its target to $165.60, but that figure is now outdated.

These target reductions indicate that analysts have become more cautious about CRH’s near-term outlook. However, the continued Buy, Outperform, and Overweight ratings suggest that several firms still see meaningful long-term potential in the company.